André Abdo
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Physiology top 5%
- Histiocytic Disorders and Treatments
Papers in
- Hematology 11
- Chronic Myeloid Leukemia Treatments 9
- Multiple Myeloma Research and Treatments 2
-
- Histiocytic Disorders and Treatments 6
- Co-authors
- Juan Carlos Yugar‐Toledo (1 shared paper)José Fernando Vilela-Martin (1 shared paper)Vanderson Rocha (4 shared papers)Valérie Taly (1 shared paper)Jean‐François Emile (1 shared paper)Julien Haroche (1 shared paper)Frédéric Charlotte (1 shared paper)Giancarlo Fatobene (1 shared paper)
- Journals
- Blood (4 papers)The Lancet Oncology (1 paper)American Journal of Hematology (1 paper)HemaSphere (1 paper)Blood Advances (1 paper)
- Partner nations
- BrazilSouth KoreaCanada
In The Last Decade
André Abdo
23 papers receiving 891 citations
André Abdo's Hit Papers
Peers
Comparison fields: 5 of 52
- Hematology 369
- Physiology 300
- Cardiology and Cardiovascular Medicine 78
- Oncology 48
- Genetics 16
Countries citing papers authored by André Abdo
This map shows the geographic impact of André Abdo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Abdo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Abdo more than expected).
Fields of papers citing papers by André Abdo
This network shows the impact of papers produced by André Abdo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Abdo. The network helps show where André Abdo may publish in the future.
Co-authors
The 25 scholars most cited alongside André Abdo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era Hit paper breakdown → | 2020 | 263 |
| 2 | A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs Hit paper breakdown → | 2021 | 242 |
| 3 | Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL Hit paper breakdown → | 2023 | 104 |
| 4 | 2010 | 78 | |
| 5 | 2020 | 53 | |
| 6 | 2018 | 48 | |
| 7 | 2020 | 26 | |
| 8 | 2020 | 21 | |
| 9 | 2016 | 12 | |
| 10 | 2016 | 11 | |
| 11 | 2020 | 10 | |
| 12 | 2020 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2018 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2020 | 3 | |
| 18 | 2020 | 2 | |
| 19 | 2021 | 2 | |
| 20 | 2021 | 2 |
About André Abdo
André Abdo is a scholar working on Hematology, Physiology, Cardiology and Cardiovascular Medicine, Oncology and Nephrology, having authored 24 papers that have together received 909 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (9 papers), Histiocytic Disorders and Treatments (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Multiple Myeloma Research and Treatments (2 papers), Pericarditis and Cardiac Tamponade (1 paper), Blood Pressure and Hypertension Studies (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and COVID-19 and healthcare impacts (1 paper). The work is most often cited by research in Hematology (369 citations), Physiology (300 citations), Cardiology and Cardiovascular Medicine (78 citations), Oncology (48 citations) and Genetics (16 citations). André Abdo has collaborated with scholars based in Brazil, South Korea and Canada. Frequent co-authors include Juan Carlos Yugar‐Toledo, José Fernando Vilela-Martin, Vanderson Rocha, Valérie Taly, Jean‐François Emile, Julien Haroche, Frédéric Charlotte, Giancarlo Fatobene, Zofia Hélias‐Rodzewicz and Juliana C. Pereira. Their work appears in journals such as Blood, The Lancet Oncology, American Journal of Hematology, HemaSphere and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.